Redesigned CD40 Agonist Antibody 2141-V11 Demonstrates Systemic Antitumor Efficacy and Enhanced Safety in Phase 1 Clinical Trials
George Ongkojoyo The landscape of cancer immunotherapy has undergone a significant transformation with the publication of new...
George Ongkojoyo
Dangerous Tapeworm Parasite Spreading Across North America Detected in Pacific Northwest Coyotes for the First Time
A resilient and potentially lethal parasite that has been migrating across the North American continent...
Mayo Clinic Researchers Uncover Novel Kidney Pathway for Water Regulation Offering New Hope for Polycystic Kidney Disease Treatment
In a landmark study that challenges decades of established physiological understanding, researchers at the Mayo...
Excess EXO1 Protein Activity Mimics BRCA Mutations and Offers New Pathway for Targeted Cancer Treatments
The fundamental understanding of oncology has long rested on the premise that tumor suppressor genes...
Naturally Occurring Bacterium from Japanese Tree Frogs Demonstrates Unprecedented Anticancer Efficacy in Preclinical Models
In a breakthrough that bridges the fields of herpetology and oncology, researchers at the Japan...
Penn State Researchers Identify EXO1 Overexpression as a Critical Driver of DNA Instability and a Novel Biomarker for Targeted Cancer Therapy
In the complex landscape of molecular biology, tumor suppressor genes have long been recognized as...
Lysosomal Trapping and Spatial Mapping Reveal Why PARP Inhibitors Show Variable Efficacy in Ovarian Cancer Patients
The fundamental mystery of modern oncology lies in the unpredictable nature of therapeutic response: why...
Scientists discover why cancer drugs don’t work for everyone
The pursuit of precision medicine in oncology has long been hindered by a fundamental paradox:...
Nagoya University Researchers Uncover How Ovarian Cancer Cells Recruit Mesothelial Cells to Accelerate Metastasis and Resist Chemotherapy
Ovarian cancer has long held a reputation as the "silent killer" of gynecological oncology, characterized...
Breakthrough in Cancer Immunotherapy: Redesigned CD40 Antibody Shows Complete Remission in Early Clinical Trials
The field of oncology is witnessing a potential paradigm shift in immunotherapy following the publication...
